Veritas Asset Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-32,262
| Closed | -$2.23M | – | 36 |
|
|
2023
Q2 | $2.23M | Sell |
32,262
-5,889,687
| -99% | -$419M | 0.02% | 38 |
|
|
2023
Q1 | $440M | Sell |
5,921,949
-67,090
| -1% | -$5.63M | 3.25% | 15 |
|
|
2022
Q4 | $558M | Sell |
5,989,039
-897,375
| -13% | -$86.6M | 4.57% | 11 |
|
|
2022
Q3 | $657M | Sell |
6,886,414
-1,640,509
| -19% | -$162M | 5.43% | 9 |
|
|
2022
Q2 | $790M | Sell |
8,526,923
-6,150,861
| -42% | -$600M | 5.9% | 5 |
|
|
2022
Q1 | $1.49B | Buy |
14,677,784
+163,000
| +1% | +$17.1M | 9.1% | 2 |
|
|
2021
Q4 | $1.5B | Buy |
14,514,784
+3,361,760
| +30% | +$311M | 8.41% | 3 |
|
|
2021
Q3 | $946M | Buy |
11,153,024
+2,975,111
| +36% | +$249M | 5.43% | 7 |
|
|
2021
Q2 | $682M | Sell |
8,177,913
-3,242,430
| -28% | -$266M | 3.82% | 15 |
|
|
2021
Q1 | $859M | Sell |
11,420,343
-291,090
| -2% | -$21.2M | 4.71% | 9 |
|
|
2020
Q4 | $800M | Buy |
11,711,433
+916,800
| +8% | +$59.6M | 4.77% | 9 |
|
|
2020
Q3 | $630M | Buy |
10,794,633
+309,570
| +3% | +$19.3M | 4.38% | 13 |
|
|
2020
Q2 | $681M | Buy |
10,485,063
+249,405
| +2% | +$15.7M | 4.99% | 11 |
|
|
2020
Q1 | $607M | Buy |
10,235,658
+2,487,300
| +32% | +$166M | 4.82% | 10 |
|
|
2019
Q4 | $576M | Buy |
7,748,358
+1,008,600
| +15% | +$70.8M | 4.93% | 10 |
|
|
2019
Q3 | $425M | Sell |
6,739,758
-5,530,000
| -45% | -$328M | 4.14% | 13 |
|
|
2019
Q2 | $669M | Buy |
12,269,758
+90,700
| +0.7% | +$4.88M | 5.7% | 7 |
|
|
2019
Q1 | $657M | Buy |
12,179,058
+254,777
| +2% | +$15.7M | 5.9% | 10 |
|
|
2018
Q4 | $781M | Buy |
11,924,281
+214,957
| +2% | +$16M | 7.24% | 3 |
|
|
2018
Q3 | $922M | Sell |
11,709,324
-181,100
| -2% | -$12.9M | 7.76% | 3 |
|
|
2018
Q2 | $765M | Buy |
11,890,424
+508,500
| +4% | +$33.5M | 6.28% | 4 |
|
|
2018
Q1 | $708M | Sell |
11,381,924
-301,600
| -3% | -$21.6M | 5.73% | 7 |
|
|
2017
Q4 | $847M | Buy |
11,683,524
+3,009,000
| +35% | +$219M | 6.58% | 5 |
|
|
2017
Q3 | $705M | Buy |
8,674,524
+235,960
| +3% | +$18.7M | 5.77% | 7 |
|
|
2017
Q2 | $679M | Buy |
8,438,564
+865,756
| +11% | +$68.4M | 5.3% | 8 |
|
|
2017
Q1 | $594M | Buy |
7,572,808
+546,800
| +8% | +$43.7M | 5.36% | 10 |
|
|
2016
Q4 | $554M | Buy |
7,026,008
+1,801,681
| +34% | +$146M | 5.9% | 9 |
|
|
2016
Q3 | $465M | Buy |
5,224,327
+415,850
| +9% | +$39.3M | 5.27% | 10 |
|
|
2016
Q2 | $460M | Buy |
4,808,477
+439,848
| +10% | +$43.8M | 5.06% | 10 |
|
|
2016
Q1 | $453M | Buy |
4,368,629
+14,600
| +0.3% | +$1.42M | 5.67% | 7 |
|
|
2015
Q4 | $426M | Buy |
4,354,029
+121,973
| +3% | +$11.9M | 5.35% | 10 |
|
|
2015
Q3 | $408M | Buy |
4,232,056
+112,100
| +3% | +$11.8M | 5.49% | 8 |
|
|
2015
Q2 | $432M | Sell |
4,119,956
-53,683
| -1% | -$5.48M | 6.09% | 8 |
|
|
2015
Q1 | $431M | Buy |
4,173,639
+115,600
| +3% | +$11.7M | 6.79% | 8 |
|
|
2014
Q4 | $391M | Sell |
4,058,039
-928,209
| -19% | -$81.8M | 6.18% | 8 |
|
|
2014
Q3 | $397M | Hold |
4,986,248
| – | – | 6.33% | 7 |
|
|
2014
Q2 | $376M | Sell |
4,986,248
-8,600
| -0.2% | -$650K | 6.35% | 7 |
|
|
2014
Q1 | $374M | Buy |
4,994,848
+309,828
| +7% | +$21.9M | 6.64% | 6 |
|
|
2013
Q4 | $335M | Buy |
4,685,020
+304,200
| +7% | +$19.5M | 6.77% | 6 |
|
|
2013
Q3 | $249M | Sell |
4,380,820
-555,880
| -11% | -$33.1M | 5.88% | 8 |
|
|
2013
Q2 | $282M | Buy |
+4,936,700
| New | +$286M | 6.73% | 6 |
|
Other funds holding CVS
Veritas Asset Management's CVS Position: Q3 2023 in Review
Veritas Asset Management sold out of CVS Health (CVS) in Q3 2023, closing a stake of 32,262 shares — an estimated $2.23M sold.
Veritas Asset Management first reported a position in CVS in Q2 2013 and held it in 41 quarters. The position peaked at $1.5B in Q4 2021. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.
- Veritas Asset Management reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
- Veritas Asset Management sold 32,262 CVS Health shares in Q3 2023, an estimated $2.23M.
- Veritas Asset Management first reported a position in CVS Health in Q2 2013 and held it in 41 quarters.
- Veritas Asset Management's CVS Health position peaked at $1.5B in Q4 2021.
- 2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.
Based on Veritas Asset Management's 13F filing for Q3 2023, filed 20 Oct 2023.